Sign in

NCT03313895Completed

The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial

Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training (ACT) in MCI

Source: ClinicalTrials.gov · Last updated 25 Apr 2025

Brief summary (registry, in English)

This multi-site clinical trial occurs at the University of Minnesota and University of Rochester. It tests the efficacy and additive/synergistic effects of an ACT intervention on cognition and relevant mechanisms (aerobic fitness, Alzheimer's disease \[AD\] signature cortical thickness, and default mode network \[DMN\]) in older adults with amnestic MCI (aMCI).

Status (registry)
Completed
Study type
Interventional
Enrollment
146 (actual)
First submitted
6 Oct 2017
Start date
5 Jul 2018
Primary completion date
17 Jul 2024
Lead sponsor
Arizona State University
NCT number
NCT03313895

What you commit to

  • Study type: Interventional
  • Participants enrolled: 146
  • From 5 Jul 2018 to the primary completion date, 17 Jul 2024
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Resting heart rate (HR) ≤50 due to arrhythmia or ≥100 beats/min
  • Neurological (e.g., dementia, head trauma), psychiatric (e.g., bipolar, schizophrenia, or depression), or substance dependency (alcohol or chemical dependency) in the past 5 years that are the main contributor to MCI
  • Contraindications to exercise, e.g. unstable angina, recent surgery
  • New symptoms or diseases that have not been evaluated by a health care provider

Other

  • Geriatric Depression Scale \< 5
  • Current enrollment in another intervention study related to cognitive improvement (reduce confounding effects on outcomes)
  • Abnormal MRI findings

Who the study is looking for

  • A clinical diagnosis of MCI
  • Community-dwelling
  • Age 65 years and older
  • English-speaking
  • Adequate visual acuity
  • Verified exercise safety by medical provider
  • Stable on drugs affecting cognitive and psychological status
  • Verified MRI safety
  • Capacity to consent

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Minnesota
Coordinator of this site? Confirm its status
MinneapolisUnited StatesUnknown status
Arizona State University
Coordinator of this site? Confirm its status
PhoenixUnited StatesUnknown status
University of Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status
Stanford University
Coordinator of this site? Confirm its status
StanfordUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.